抗精神病药物所致帕金森症的病理生理机制
Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism.
作者信息
Vaiman Elena E, Shnayder Natalia A, Khasanova Aiperi K, Strelnik Anna I, Gayduk Arseny J, Al-Zamil Mustafa, Sapronova Margarita R, Zhukova Natalia G, Smirnova Daria A, Nasyrova Regina F
机构信息
V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Institute of Personalized Psychiatry and Neurology, 192019 St. Petersburg, Russia.
Shared Core Facilities Molecular and Cell Technologies, V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia.
出版信息
Biomedicines. 2022 Aug 18;10(8):2010. doi: 10.3390/biomedicines10082010.
Among neurological adverse reactions in patients with schizophrenia treated with antipsychotics (APs), drug-induced parkinsonism (DIP) is the most common motility disorder caused by drugs affecting dopamine receptors. One of the causes of DIP is the disruption of neurotransmitter interactions that regulate the signaling pathways of the dopaminergic, cholinergic, GABAergic, adenosinergic, endocannabinoid, and other neurotransmitter systems. Presently, the development mechanisms remain poorly understood despite the presence of the considered theories of DIP pathogenesis.
在使用抗精神病药物（APs）治疗的精神分裂症患者的神经不良反应中，药物性帕金森综合征（DIP）是由影响多巴胺受体的药物引起的最常见的运动障碍。DIP的原因之一是调节多巴胺能、胆碱能、γ-氨基丁酸能、腺苷能、内源性大麻素和其他神经递质系统信号通路的神经递质相互作用受到破坏。目前，尽管存在关于DIP发病机制的相关理论，但对其发展机制仍知之甚少。
Zotero 插件